This site uses cookies to bring you the best experience. Find out more
Skip to main content

Vascular Society

Vascular Society website 

To relieve sickness and to preserve, promote and protect the health of the public by advancing excellence and innovation in vascular health, through education, audit and research.

 


Professor Ian Chetter, President, Vascular Society

Professor Ian Chetter was appointed as the Professor of Surgery at Hull York Medical School /University of Hull and Honorary Consultant Vascular Surgeon at Hull University Teaching Hospitals NHS Trust in February 2011. He qualified from University of Leeds Medical School in 1990, and completed his basic and higher surgical training in Yorkshire. Funded by a Northern and Yorkshire Research Fellowship, he obtained MD from the University of Leeds and was awarded a Hunterian Professorship from the Royal College of Surgeons of England in 2000. Following a 12 month Vascular Fellowship in Adelaide, Australia funded by an Ethicon/ Peter Clifford Fellowship in 2002/3, Ian returned to the UK to be appointed Senior Lecturer at the Academic Vascular Surgical Unit in Hull.

Currently, he serves as the President of the Vascular Society of GB&I and has previously held executive committee roles including Chair of the Research Committee. He was the first Royal College of Surgeons Surgical Specialty Lead for Research in Vascular Surgery and a recipient of an NIHR Senior Investigators Award.

In addition to his organisational roles, Professor Chetter is the Editor in Chief of the Journal of Vascular Societies GB&I. He also contributes to the National Institute for Health Research (NIHR) as a member of the Prioritisation Committee, is an examiner for Intercollegiate Speciality Exams in Vascular Surgery and is a member of the Scientific Committee for the Wounds Research Network.

His research interests include Health Services Research, New and Emerging Technologies in arterial and venous disease, wound healing, surgical site infection, and molecular biology of aneurysmal disease. He also explores translational research in therapies for intermittent claudication and educational research on the value of endovascular simulation.

Professor Chetter has been involved in numerous successful and ongoing NIHR programme awards, including as lead applicant for an NIHR Health Technology Assessment (HTA) SWHSI 2, focusing on the effectiveness and cost-effectiveness of Negative Wound Therapy versus usual care for surgical wounds healing by secondary intention.

Upcoming Events

Latest News